IMNM

Immunome, Inc.
Data: 2026-08-03

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

Quick Stats
Aug 03, 2026

50.6

AI Score

HOLD

0.47

Volume Ratio

Aug 05, 2026

Next Earnings

19

+ve Days (30d)

11

-ve Days (30d)

IMNM Stock Summary

Last updated Aug 03, 2026

IMNM is currently trading at $22.88, positioned above its 200-day moving average of $21.0, indicating a long-term uptrend. The stock has a 52-week range of $8.665 to $27.65.

Technical Analysis: The 50-day moving average stands at $21.27, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 55.514, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.008, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates IMNM at 50.6/100 with a HOLD recommendation.

IMNM (Immunome, Inc.) Indicators

Last updated Aug 03, 2026

Indicator Value
RSI(14) 55.514
CMF (20) -0.008
ROC (10) 3.272
ADX (14) 26.553
Indicator Value
MACD (12,26,9) 0.391
AROONOSC (14) 57.143
WILLAMS %R (14) -40.868
MFI (14) 40.096
IMNM Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

IMNM Price vs Max Options Open Interest
IMNM Max Change In Options Open Interest

IMNM Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

IMNM Daily Out of Money Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

IMNM Daily In the Money Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

IMNM Most Active Options by Volume(near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Immunome, Inc. is above both the 50 Day and 200 Day SMA which is considered Bullish.

IMNM Moving Averages Analysis

Immunome, Inc. has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Aug 03, 2026

Immunome, Inc. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Aug 03, 2026

IMNM (Immunome, Inc.) Simple Moving Averages

Moving Averages are last updated Aug 03, 2026

Days MA
10 22.75
20 22.92
30 22.24
50 21.27
100 21.62
200 21.0

IMNM Fundamental Analysis

P/E (Forward) --
P/E (Trailing) --
Market Cap ($) 2.6 billion
Earnings/Share ($) -2.39
Net Profit Margin (%) --
Dividend/Share ($) --
EPS Estimate Current Year ($) -2.1247
EPS Estimate Next Year ($) -2.1196
WallStreet Target Price ($) 35.77
Most Recent Quarter